Jump Financial, LLC Biogen Inc. Transaction History

Jump Financial, LLC

$4.56 Billion
Q3 2024

A detailed history of Jump Financial, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 56,669 shares of BIIB stock, worth $8.54 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

56,669

Previous 7,705 635.48%

Holding current value

$8.54 Million

Previous $1.79 Million 515.01%

% of portfolio

0.24%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $9.26 Million - $11.6 Million	48,964 Added 635.48%	56,669 $11 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $10.7 Million - $13.3 Million	-56,061 Reduced 87.92%	7,705 $1.79 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $13.2 Million - $16.7 Million	62,429 Added 4669.33%	63,766 $13.7 Million
Q4 2023 Oct 21, 2024	SELL	$222.59 - $267.94 $177,626 - $213,816	-798 Reduced 37.38%	1,337 $345,000
Q4 2023 Feb 07, 2024	BUY	$222.59 - $267.94 $297,602 - $358,235	1,337 New	1,337 $345,000
Q2 2023 Oct 21, 2024	SELL	$275.25 - $318.06 $1.53 Million - $1.77 Million	-5,570 Reduced 72.29%	2,135 $608,000
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $587,658 - $679,058	2,135 New	2,135 $608,000
Q3 2022 Nov 07, 2022	SELL	$194.69 - $268.46 $2.94 Million - $4.06 Million	-15,109 Reduced 94.23%	925 $247,000
Q2 2022 Aug 09, 2022	BUY	$187.54 - $223.02 $2.83 Million - $3.36 Million	15,079 Added 1578.95%	16,034 $3.27 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $83,127 - $104,736	-429 Reduced 31.0%	955 $201,000
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $309,905 - $398,273	1,384 New	1,384 $332,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $303,931 - $396,359	-1,074 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $278,166 - $445,398	1,074 New	1,074 $372,000

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Account

Jump Financial, LLC Biogen Inc. Transaction History